These putative oncogenic roles generally result from cyclin D1 overexpression, and the mechanisms of overexpression are largely unknown, although genomic CCND1 amplification or translocation accounts for overexpression in subsets of human cancer, including breast cancers and lympoma29,30. The gene discussed is CCND1; the disease is breast cancer.